mile high retatrutide π is the most powerful weight loss drug ever trialled. 28.7 percent average body weight loss in 68 weeks. Some participants lost over 30 percent of their starting body weight. The Retatrutide Provides Substantial Weight Loss
Description
Particularly noteworthy is that in patients with both type 2 diabetes and MASLD, after 24 weeks of treatment with a 10 mg dose of efinopegdutide, liver fat content reduced by 72.7%, a result that is superior to the 42.3% reduction achieved with a 1 mg dose of semaglutide, despite a similar overall weight loss being observed with the two interventions

Whilst no additional degradation was observed with exendin-asp3, this was noticeably reduced with exendin-phe1 (Fig
The transition bumps
The log 10 P value for enrichment is represented on the x axis
GLP-1 Receptor Activation GLP-1 receptors are expressed in cardiac tissue, and their activation promotes a modest sympathomimetic effect